4//SEC Filing
SKELLY WILLIAM G 4
Accession 0001104659-22-001474
CIK 0000786947other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:15 PM ET
Size
10.5 KB
Accession
0001104659-22-001474
Insider Transaction Report
Form 4
SKELLY WILLIAM G
Director
Transactions
- Exercise/Conversion
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 0 total→ Common Stock (66,666 underlying) - Award
Restricted Stock Units (2021 Plan)
2022-01-03−66,666→ 66,666 total→ Common Stock (66,666 underlying) - Exercise/Conversion
Common Stock
2022-01-03+66,666→ 459,323 total
Footnotes (7)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]66,666 Restricted Stock Units were granted on May 25, 2021. 50% of Restricted Stock Units vested on the last day of June 2021, while 25% of Restricted Stock Units vested on the last day of September 2021 and December 2021. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]66,666 Restricted Stock Units were granted on January 3, 2022. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2022, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2023, or earlier upon a change of control.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001058352
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:15 PM ET
- Size
- 10.5 KB